Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine plus paravertebral block for non-intubated thoracoscopic surgery
ChiCTR2400085737Phase 4Recruiting
- Sponsor
- Qujing No. 1 Hospital
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esketamine in lung nodule (SPN) and Pulmonary bulla (2 arms), sponsored by Qujing No. 1 Hospital. Primary endpoint: Arterial and venous blood gas analysis. Started Jun 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
lung nodule (SPN)Pulmonary bulla
Beyond the preview
Go deeper on ChiCTR2400085737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085737.